Human keratinocytes lack the components to produce leukotriene B4

Journal of Investigative Dermatology

Volumn 106, Issue 1, 1996, Pages 162-167

  Breton, John ^a   Woolf, Deborah ^a   Young, Peter ^a   Chabot Fletcher, Marie ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

5 Lipoxygenase; 5 Lipoxygenase activating protein; Arachidonic acid

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; BRADYKININ; CALCIMYCIN; LEUKOTRIENE B4; PHORBOL ESTER; PROSTAGLANDIN E2;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; KERATINOCYTE; MALE; NEWBORN; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030033744     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12329890     Document Type: Article

References (33)

1. 4. Br J Dermatol 114:409-412, 1986
2. Black AK, Camp RDR, Mallet AI, Cunningham FM, Hofbauer M, Greaves MW: Pharmacologic and clinical effects of lonapolene (RS 43179), a 5-lipoxygenase inhibitor, in psoriasis. J Invest Dermatol 95:50-54, 1990
3. 4. Clin Biochem 23:459-468, 1990
4. 4 synthesis. Inflammation 14:151-162, 1990
5. Böyum A: Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21(suppl 97):77-89, 1968
6. Bradford MM: A rapid and sensitive method for the quantifation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
7. 4-like material in biologically active amounts from the lesional skin of patients with psoriasis. J Invest Dermatol 83:70-73, 1984
8. Breton J, Keller P, Chabot-Fletcher M, Hillegass L, DeWolf W Jr, Griswold D: Use of a continuous assay of oxygen consumption to evaluate the pharmacology of 5-lipoxygenase inhibitors. Prost Leuk Essential Fatty Acids 49:929-937, 1993
9. Burrall BA, Cheung M, Chiu A, Goetzl EJ: Enzymatic properties of the 15-lipoxygenase of human cultured keratinocytes. J Invest Dermatol 91:294-297, 1988
10. 4. J Invest Dermatol 82:202-204, 1984
11. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987
12. 3 upregulates 5-lipoxygenase metabolism and 5-lipoxygenase activating protein in peripheral blood monocytes as they differentiate into mature macrophages. J Lipid Med 6:43-51, 1993
13. Colatta F, Peri G, Villa A, Montovani A: Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. 1. Effectors belong to the monocyte-macrophage lineage. J Immunol 132:936-944, 1984
14. Dixon RAF, Diehl RE, Opas E, Rands E, Vickers PJ, Evans JF, Gillard JW, Miller DK: Requirement of a 5-lipoxygenase-activating protein tor leukotriene synthesis. Nature 343:282-284, 1990
15. Ford-Hutchinson AW: 5-Lipoxygenase activation in psoriasis: a dead issue? Skin Pharmacol 6:292-297, 1993
16. Ford-Hutchinson AW, Gresser M, Young RN: 5-Lipoxygenase. Annu Rev Biochem 63:383-417, 1994
17. 4-like chemotactic arachidonate metabolites from human keratinocytes. J Invest Dermatol 85:527-530, 1985
18. 4 hydrolase. J Invest Dermatol 100:293-298, 1993
19. Janßen-Timmen U, Vickers F, Beilecke U, Lehmann WD, Stark H-J, Fusenig NK, Rosenbach T, Goerig M, Kadmark O, Samuelsson B, Habenicht AJR: 5-Lipoxygenase expression in cultured human keratinocytes. Adv Prost Thromb Leuk Res 23:329-331, 1995
20. 2 production by mouse kupffer cells. Prost Leuk Essential Fatty Acids 40:275-279, 1990
21. 4. Nature 227:680-685, 1970
22. Marcelo CL, Duell EA, Rhodes LM, Dunham WR: In vitro model of essential fatty acid deficiency. J Invest Dermatol 99:703-708, 1992
23. 2. J Invest Dermatol 102:980-986, 1994
24. Meyers CA, Johanson KO, Miles LM, McDevitt PJ, Simon PL, Webb RL, Chen M-J, Holskin BP, Lillquist JS, Young PR: Purification and characterization of human recombinant interleukin-1 beta. J Biol Chem 262:11176-11181, 1987
25. Miller DK, Gillard JW, Vickers PJ, Sadowski S, Léveillé C, Mancini JA, Charleson P, Dixon RAF, Ford-Hutchinson AW, Fortin R, Gauthier JY, Rodkey J, Rosen R, Rouzer C, Sigal IS, Strader CD, Evans JF: Identification and isolation of a membrane protein necessary for leukotriene production. Nature 343:278-281, 1990
26. Pentland AP, Mahoney MG: Keratinocyte prostaglandin synthesis is enhanced by IL-1. J Invest Dermatol 94:43-46, 1990
27. Reid GK, Kargman S, Vickers PJ, Mancini JA, Léveillé C, Ethier D, Miller DK, Gillard JW, Dixon RAF, Evans JF: Correlation between expression of 5-lipoxygenase-activating protein, 5-lipoxygenase, and cellular leukotriene synthesis. J Biol Chem 265:19818-19823, 1990
28. Rogozinski M: The methanol-sulfuric acid esterification method. An improved extraction procedure. J Gas Chromatog 2:328-329, 1964
29. Rosenbach T, Czernielewski J, Hecker M, Czarnetzki B: Comparison of eicosanoid generation by highly purified human Langerhans cells and keratinocytes. J Invest Dermatol 95:104-107, 1990
30. Ruzicka T, Simmet T, Peskar BA, Ring J: Skin Levels of arachidonic acid-derived inflammatory mediators and histamine in a topic dermatitis and psoriasis. J Invest Dermatol 86:105-108, 1986
31. 4. Gen Pharmacol 12:211-216, 1981
32. 4 by transcellular biosynthesis. J Invest Dermatol 98:333-339, 1992
33. Woods JW, Evans JF, Ethier D, Scott S, Vickers PJ, Hearn L, Heibein JA, Charleson S, Singer H: 5-Lipoxygenase and 5-Lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. J Exp Med 178:1935-1946, 1993